Paratek Pharmaceuticals, Inc. has opened a new Philadelphia office. The new office is located in King of Prussia, Pennsylvania.
"With two important antibiotic products in development, we have been growing our team rapidly. Our presence in Philadelphia enables us to attract world-class talent from the area's biopharmaceutical industry," said Evan Loh, President and Chief Medical Officer, Paratek. "This has already helped us identify and recruit key talent and will be critical as we continue to grow going forward."
Paratek, which is headquartered in Boston, opened its Philadelphia-area office in King of Prussia. The company currently employs 11 people in the Philadelphia region and expects to add to its local headcount over the next year as it advances its lead clinical development product candidate, omadacycline.